Malaria diagnosis for malaria elimination : Current Opinion in Infectious Diseases Malaria
diagnosis for malaria elimination : Current Opinion in Infectious Diseases Log in or Register …

Initiatives to eradicate malaria have a good impact on P. falciparum malaria worldwide. P.
vivax, however, still presents significant difficulties. This is due to its unique biological traits …

Tafenoquine is an 8-aminoquinoline under investigation for the prevention of relapse in
Plasmodium vivax malaria. This open-label, dose-escalation study assessed quantitatively …

Glucose-6-phosphate dehydrogenase (G6PD) deficiency, a common genetic blood
condition, can result in kernicterus at birth, and later in life as severe hemolysis on exposure …

Abstract Glucose‐6‐phosphate dehydrogenase (G6PD) deficiency is one of the most
common X‐linked enzymopathies caused by G6PD gene variant. We aimed to provide the …

Plasmodium vivax poses unique challenges for malaria control and elimination, notably the
potential for relapses to maintain transmission in the face of drug-based treatment and …

Plasmodium vivax radical cure requires the use of primaquine (PQ), a drug that induces
haemolysis in glucose-6-phosphate dehydrogenase deficient (G6PDd) individuals, which …

A barrier to eliminating Plasmodium vivax malaria is inadequate treatment of infected
patients. 8-Aminoquinoline–based drugs clear the parasite; however, people with glucose-6 …

Summary Glucose‐6‐phosphate dehydrogenase (G6PD) deficiency in erythrocytes causes
acute haemolytic anaemia upon exposure to fava beans, drugs, or infection; and it …

Plasmodium vivax malaria continues to cause a significant burden of disease in the Asia-
Pacific, the Horn of Africa, and the Americas. In addition to schizontocidal treatment, the 8 …